NIP
EVH icon

Nicholas Investment Partners’s Evolent Health EVH Stock Holding History

Nicholas Investment Partners’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-131,169
Closed -$1.94M – 263
2016
Q4 		$1.94M Buy
+131,169
New +$2.58M 0.15% 232

Other funds holding EVH

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Nicholas Investment Partners's EVH Position: Q1 2017 in Review

Nicholas Investment Partners sold out of Evolent Health (EVH) in Q1 2017, closing a stake of 131,169 shares — an estimated $1.94M sold.

Nicholas Investment Partners first reported a position in EVH in Q4 2016 and held it in 1 quarter. The position peaked at $1.94M in Q4 2016. 131 funds tracked by Wall St. Rank hold EVH as of Q1 2017.

  • Nicholas Investment Partners reported no remaining Evolent Health position as of Q1 2017 after selling out during the quarter.
  • Nicholas Investment Partners sold 131,169 Evolent Health shares in Q1 2017, an estimated $1.94M.
  • Nicholas Investment Partners first reported a position in Evolent Health in Q4 2016 and held it in 1 quarter.
  • Nicholas Investment Partners's Evolent Health position peaked at $1.94M in Q4 2016.
  • 131 funds tracked by Wall St. Rank held Evolent Health as of Q1 2017.

Based on Nicholas Investment Partners's 13F filing for Q1 2017, filed 15 May 2017.